UA Cancer Center Receives $8.6M Grant to Lead One of Three NCI Clinical Trials Networks
Under this funding mechanism, the UA Cancer Center serves as a lead academic organization with 12 affiliated organizations working together to perform early-phase cancer-prevention clinical trials. The network is composed of a team of physicians from diverse specialties, statisticians, clinical staff, data managers, pathologists, translational scientists and other personnel with extensive experience in early-phase (phase 0, I or II) cancer-prevention clinical trials.
Community Outreach and Engagement bridges the Cancer Center and the communities it serves to address the unequal burden of cancer for Arizonans through culturally relevant research, training and community outreach.
Our 16 multidisciplinary disease teams include physicians and health care professionals, offering hundreds of trials to patients.
The UA Cancer Center’s 165 research members, across 10 colleges and 39 departments, bring the power of research to cancer prevention and treatment.
The only National Cancer Institute-designated Comprehensive Cancer Center headquartered in the state of Arizona.
Bringing promising new therapies from the laboratory to the bedside is a high priority. The clinician scientists of the University of Arizona Cancer Center are engaged in more than 200 clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.
Hundreds of doctors, scientists, postdoctoral fellows, graduate students, undergraduate students and technicians work in 73 research laboratories in the University of Arizona Cancer Center. Armed with test tubes, cancer cells, computers and tumor models, they search for the missing pieces of the cancer puzzle in their efforts to prevent and cure cancer.
The University of Arizona Cancer Center has four established scientific Research Programs that work together to accomplish the Center’s mission to prevent and cure cancer.
Our researchers at the University of Arizona Cancer Center collaborate concerning a breadth of issues, from benchtop to bedside, involving translational and clinical research with a major emphasis on discovery.